Primary CNS tumors with MYC alterations include but are not limited to oligodendroglioma, adult and pediatric gliomas regardless of IDH status, central neurocytoma, spinal ependymoma, medulloblastoma, AT/RT, pineoblastoma, and diffuse large B-cell lymphoma [5]. This evidence concerns the gene IDH1 and medulloblastoma.